SCHEMBL10319232

SCHEMBL10319232

CC(C)(C)OC(=O)NCC[C@H](c1ccccc1)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UTS2R Q9UKP6 3/20 0.56
MALT1 Q9UDY8 1/20 0.50
ALDH1A1 P00352 1/20 0.46
HSD17B10 Q99714 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
KCNA5 P22460 1/20 0.45
PDCD1 Q15116 1/20 0.43
CD274 Q9NZQ7 1/20 0.43
TNF P01375 4/20 0.43
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
KMT2A Q03164 1/20 0.43
CTSS P25774 1/20 0.43
CTSK P43235 1/20 0.43
TPSAB1 Q15661 1/20 0.42
TPSD1 Q9BZJ3 1/20 0.42
TPSG1 Q9NRR2 1/20 0.42
IDO1 P14902 1/20 0.42
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10318215 1.00 UTS2R (0.56) UTS2RMALT1ALDH1A1HSD17B10L3MBTL1
SCHEMBL10318216 1.00 UTS2R (0.56) UTS2RMALT1ALDH1A1HSD17B10L3MBTL1
SCHEMBL20768584 0.92 UTS2R (0.52) UTS2RMALT1ALDH1A1HSD17B10L3MBTL1
SCHEMBL11890478 0.92 UTS2R (0.50) UTS2RMALT1ALDH1A1HSD17B10L3MBTL1
SCHEMBL19331975 0.91 UTS2R (0.51) UTS2RMALT1ALDH1A1HSD17B10L3MBTL1
SCHEMBL20768610 0.90 UTS2R (0.56) UTS2RMALT1ALDH1A1HSD17B10L3MBTL1
SCHEMBL19331808 0.88 UTS2R (0.55) UTS2RMALT1KCNA5PDCD1CD274
SCHEMBL10319514 0.88 UTS2R (0.55) UTS2RMALT1ALDH1A1KCNA5PDCD1
SCHEMBL8242699 0.88 UTS2R (0.54) UTS2RMALT1ALDH1A1HSD17B10L3MBTL1
SCHEMBL10447571 0.88 UTS2R (0.54) UTS2RMALT1ALDH1A1HSD17B10L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012098070-A1 QUINOLINE DYRK1 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 WO disclosed
WO-2012098065-A1 PYRIDO PYRIMIDINES FOR USE AS DYRK1 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 WO disclosed
WO-2012098070-A1 QUINOLINE DYRK1 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 WO disclosed
US-20120184542-A1 PYRIDO PYRIMIDINES ANDERSON KEVIN (US) 2012-07-19 US disclosed
US-20120184548-A1 CARBOXYLIC ACID ARYL AMIDES DOMINIQUE ROMYR (US) 2012-07-19 US disclosed
US-20120184542-A1 PYRIDO PYRIMIDINES ANDERSON KEVIN (US) 2012-07-19 US disclosed
US-20120184542-A1 PYRIDO PYRIMIDINES ANDERSON KEVIN (US) 2012-07-19 US disclosed
US-20120184548-A1 CARBOXYLIC ACID ARYL AMIDES DOMINIQUE ROMYR (US) 2012-07-19 US disclosed
US-20120184548-A1 CARBOXYLIC ACID ARYL AMIDES DOMINIQUE ROMYR (US) 2012-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184548-A1 CARBOXYLIC ACID ARYL AMIDES GOT1, PPARG, PPARA UTS2R 1776/4885MALT1 1218/4885ALDH1A1 62/4885
US-20120184542-A1 PYRIDO PYRIMIDINES TYMS, TYMP, DPYD UTS2R 911/4885MALT1 4462/4885ALDH1A1 2619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.